| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,161,000 | 1,961,000 | 2,125,000 | 1,936,000 | | Cost of Revenue | 480,000 | (225,000) | 523,000 | 447,000 | | | Gross Profit | 1,681,000 | 2,186,000 | 1,602,000 | 1,489,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 97,000 | 824,000 | 83,000 | 89,000 | | Non Recurring | (6,000) | (3,000) | 45,000 | (26,000) | | Others | 709,000 | 656,000 | 505,000 | 420,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 881,000 | 709,000 | 969,000 | 1,006,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 881,000 | 709,000 | 969,000 | 1,006,000 | | Interest Expense | 126,000 | 157,000 | 132,000 | 102,000 | | Income Before Tax | 755,000 | 552,000 | 837,000 | 904,000 | | Income Tax Expense | 269,000 | 201,000 | 316,000 | 329,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 486,000 | 351,000 | 521,000 | 575,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 486,000 | 351,000 | 521,000 | 575,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $486,000 | $351,000 | $521,000 | $575,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
